WITHDRAWN: Identification of death-associated protein-like 1 (DAPL1) as a novel prognostic biomarker of breast cancer
Authors:
Preprint
- 26 February 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: It is meaningful to identify the potential clinical prognosis-associated oncogenes for cases with breast cancer, considering the complicated pathogenesis of breast cancer.Methods: We first utilized the bioinformatics approach to investigate the role of the DAPL1 (death-associated protein-like 1) in breast cancer, based on the available datasets of TCGA and GEO.Results: DAPL1 is lowly expressed in breast cancer tissues compared with the normal tissues. For the breast cancer cases of the TCGA-BRCA cohort, we observed a correlation between lowly expressed DAPL1 gene and poor clinical prognosis of overall survival ( P =0.0028). Based on the survival data of GEO, the low DAPL1 expression was associated with a poor prognosis of distant metastasis free survival ( P =0.0023), and relapse free survival ( P =0.0065). DAPL1 expression was linked to the mutation status or copy number variation o f several genes, such as MAP3K1 , NUP98 , and CCDC59. The infiltration level of immune cells (e.g., M1 macrophage, Follicular B helper T cells, etc.) may be involved in the etiology of breast cancer. Based on the DAPL1 -correlated genes, GSEA, GO, and KEGG analysis data indicated the association between DAPL1 expression and a series of biological issues, such as DNA packaging complex, DNA repair complex, nucleotide excision repair, ubiquitin-like protein binding, and ubiquitin proteasome pathway. We also identified several DAPL1 -associated phosphorylation kinases, such as MAPK, PRKACA, and GSK3B.Conclusions: DAPL1 gene is first identified as a prognosis biomarker of breast cancer, and the underlying molecular mechanism involves protein phosphorylation, immune cell infiltration, and DNA repair or protein ubiquitin-associated cellular pathways.Keywords
This publication has 26 references indexed in Scilit:
- Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicineSeminars in Cancer Biology, 2018
- Association Between Genomic Metrics and Immune Infiltration in Triple-Negative Breast CancerJAMA Oncology, 2017
- UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival AnalysesNeoplasia, 2017
- DAPL1, a susceptibility locus for age-related macular degeneration, acts as a novel suppressor of cell proliferation in the retinal pigment epitheliumHuman Molecular Genetics, 2017
- A Practical Guide to The Cancer Genome Atlas (TCGA)2016
- The Gene Expression Omnibus Database2016
- A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD)NeuroMolecular Medicine, 2015
- Whole genome expression profiling in chewing-tobacco-associated oral cancers: a pilot studyMedical Oncology, 2015
- An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsBreast Cancer Research and Treatment, 2009
- The gene associated with trichorhinophalangeal syndrome in humans is overexpressed in breast cancerProceedings of the National Academy of Sciences, 2005